Product Information
ALLERGY-CONGES RELF ER TABLET is a generic product labeled by AmerisourceBergen, priced at $0.5535 per EA under NDC 46122038322. Its NADAC has been published 389 times since Apr 24, 2019.
FDA first approved this application on Sep 22, 2004.
Strength
10; 240 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122038322
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORATADINE; PSEUDOEPHEDRINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA076557FDA Approved
9/22/2004
On Market Since
8/2/2017
Pharmacological Classes
Price Statistics
The NADAC for ALLERGY-CONGES RELF ER TABLET has been published 389 times since Apr 24, 2019, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5535 per EA |
|---|---|
| All-time high | $0.5950 (Nov 13, 2024) |
| All-time low | $0.4743 (Nov 17, 2021) |
| 52-week high | $0.5851 |
| 52-week low | $0.5307 |
| Median price | $0.5248 |
| Average price | $0.5293 |
| Largest weekly change | +21.7% (Aug 21, 2024) |
| Weeks tracked | 389 |
| Tracking since | Apr 24, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
loratadine and pseudoephedrine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALLERGY-CONGES RELF ER TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALLERGY-CONGES RELF ER TABLET, manufactured by AmerisourceBergen, is $0.5535 per EA (NDC 46122038322), effective Sep 30, 2026.
How has the price of ALLERGY-CONGES RELF ER TABLET changed over time?
Over the history we have for it, the NADAC for ALLERGY-CONGES RELF ER TABLET has risen 9.7%. It has been tracked across 389 weekly CMS publications since Apr 24, 2019.
What are the highest and lowest recorded NADAC prices for ALLERGY-CONGES RELF ER TABLET?
Since Apr 24, 2019, the NADAC for ALLERGY-CONGES RELF ER TABLET has ranged from a low of $0.4743 (Nov 17, 2021) to a high of $0.5950 (Nov 13, 2024), with a median of $0.5248 per EA.
Are there cheaper alternatives to ALLERGY-CONGES RELF ER TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALLERGY-CONGES RELF ER TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALLERGY-CONGES RELF ER TABLET?
ALLERGY-CONGES RELF ER TABLET (NDC 46122038322) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.